Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. - Wikidata - wikimedia - TriplyDB

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

http://www.wikidata.org/entity/Q36949578

about

HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation HIV Genome-Wide Protein Associations: a Review of 30 Years of Research Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.The activity of Nef on HIV-1 infectivity Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity

P2860

Q24338895-8F49F746-0A81-404B-8F62-236760C50F2B Q26746070-5A032385-FEE7-4A04-8119-8FDD96D57345 Q26767362-A1C4B25B-7288-4712-AD01-39FB8A5573BF Q33567639-D720E710-24E2-4A5D-8141-0E997D438FAF Q33826603-50031C48-3AB5-405F-AE95-1AA52F0ABFD3 Q33927183-D1A7AACC-07F2-4995-9BAD-8B26015D6313 Q34109778-76FB694E-9333-4644-AA00-F7E9B839551E Q36759728-99EB1150-A466-4366-B37B-2D1B9F4967C2 Q37469506-F3CFD522-58F5-4029-8E66-6C56F5098855 Q37959034-47576531-FFB0-4F0C-BB1A-E63EFE85E601 Q38218107-9B29FDAE-EF43-461B-B011-22BD881C01DF Q39577894-5AE09ABB-215D-4A22-8D14-4575941A38BC Q40301185-509EAB2E-0D94-4FAD-A89C-FC1E1BD9595F Q40857639-63C58113-2563-4D28-B7A8-D7A384DFEEEE Q42125314-80F978CB-052B-495A-AAB0-CD6032E60551

P2860

Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

http://www.wikidata.org/entity/Q36949578

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Nef can enhance the infectivit ...... ciency virus type 1 particles.

@en

type

label

Nef can enhance the infectivit ...... ciency virus type 1 particles.

@en

prefLabel

Nef can enhance the infectivit ...... ciency virus type 1 particles.

@en

P1433

Q36949578-C6007C70-7C01-460B-892A-ABF33C0A78DE

P1476

Q36949578-901D031C-7088-4C2B-8ECD-9D854CEE9AB5

P2093

Q36949578-CBB6B6D3-722C-412C-9666-EB7C2AC82E14

Q36949578-D54D3D81-B5AD-4162-879F-210D32C84E27

Q36949578-E242E418-E4EF-4179-BEF3-47167BF26BB7

P2860

Q36949578-01AB58B7-CF8B-4DF1-B057-529AAC351D3F

Q36949578-0434EE37-AE0B-47D0-8911-601E8CADCFF3

Q36949578-0850A69A-575A-4CD5-8491-77CA6C57EDFE

Q36949578-0A2B1209-99D8-41C3-A5FF-C7D2887847B9

Q36949578-0CBC695E-6D25-4B95-8011-7EB5A0218F62

Q36949578-0D5F4B5D-92B9-4B04-934E-4D6C78FEB4C7

Q36949578-120ACB58-65B9-4C8E-A4E7-B64B25512582

Q36949578-136AF228-8E9A-4EC5-9C12-345A54BAC91B

Q36949578-1C9EEA68-F0BD-46B7-93EC-CFB32C3D5705

Q36949578-1D65B9E8-960B-4483-BCE0-1970EA1BB725

P304

Q36949578-1B3467AA-39C5-48B4-A97E-11A38B13F5EE

P31

Q36949578-21370311-A0A1-406A-ACBC-44DEE836D65D

P356

Q36949578-DAF88EFE-023E-4CB1-9966-FC9BC68E1134

P407

Q36949578-3733CEA4-455D-4414-B4B4-EB478626205E

P433

Q36949578-F5444ECE-0634-4381-B231-EE4DBF94E90E

P478

Q36949578-29CA5965-544C-4928-BE4E-3869EF3F95B5

P577

Q36949578-6C81AE27-DA65-48BC-8016-74772BCFBBDC

P5875

Q36949578-28FC27D6-45B2-45D6-8B86-0B7415F7BBB7

P698

Q36949578-E946389D-0C87-4F00-9B37-7521B2C1E56A

P932

Q36949578-247F2C56-D473-4F2F-BF9D-D6390AEF0937

P356

P1433

Journal of Virology

P1476

Nef can enhance the infectivit ...... ciency virus type 1 particles.

@en

P2093

Elena Popova

http://www.w3.org/2001/XMLSchema#string

Heinrich G Göttlinger

http://www.w3.org/2001/XMLSchema#string

Massimo Pizzato

http://www.w3.org/2001/XMLSchema#string

P2860

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail

Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain

Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins

The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]

Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating

Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity

The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

P304

10811-10819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01150-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23183117

http://www.w3.org/2001/XMLSchema#string

P698

18715908

http://www.w3.org/2001/XMLSchema#string

P932

2573167

http://www.w3.org/2001/XMLSchema#string